Fetal acetaminophen exposure increases the likelihood that a child will develop attention-deficit/hyperactivity disorder (ADHD), according to a new study.
Discover how acetaminophen use during pregnancy may elevate ADHD risk in children. Learn about the implications of prenatal ...
1d
News Medical on MSNStudy links fetal acetaminophen exposure to increased risk of ADHDFetal acetaminophen exposure increases the likelihood that a child will develop attention-deficit/hyperactivity disorder (ADHD), according to a study published Feb. 6 in Nature Mental Health.
1d
News Medical on MSNExploring EGCG's role in protecting against acetaminophen-induced liver injuryAnnouncing a new publication for Acta Materia Medica journal. Excessive consumption of acetaminophen (APAP) has emerged as the primary culprit behind drug-induced liver injury (DILI), with ...
A new lawsuit claims that a hairstylist developed bladder cancer from working with a dye chemical for decades. The verdict: ...
Workplace Bullying's Sleep Impact Spreads to Partners, reveals studyWorkplace bullying affects not only the employee’s sleep ...
Informed by my 20 years of caring for women as an OB/GYN physician, I believe it is critical that American women be equipped ...
Right now, the FDA has approved the new drug to treat pain from an injury or surgery. Its manufacturer is also testing it for ...
Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.
Here to help break down this new painkiller is Dr. Sean Mackey. He’s a Professor of Anesthesiology and Medicine at Stanford ...
The US FDA has approved Journavx, a new pain reliever without the risks for addiction or overdose linked to drugs like Vicodin and OxyContin.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results